表紙
市場調查報告書
商品編碼
1068115

直腸陰道瘺治療的全球市場:產業分析,市場規模,佔有率,成長,趨勢,預測(2021年∼2031年)

Recto-vaginal Fistula Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

出版日期: | 出版商: Transparency Market Research | 英文 200 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球直腸陰道瘺治療的市場調查分析,提供市場概要,市場分析,促進因素·阻礙因素·趨勢,競爭情形,企業簡介等系統性資訊。

目錄

第1章 序文

第2章 前提條件與調查手法

第3章 摘要整理:全球直腸陰道瘺治療市場

第4章 市場概要

  • 簡介
  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 全球直腸陰道瘺治療市場分析與預測,2017年∼2031年
    • 市場收益預測(金額)

第5章 重要的洞察

  • 治療方法/醫藥品的進步與創新
  • 疾病流行病學分析
  • 主要的產業活動(合併,收購,協定/夥伴關係等)
  • COVID-19疫情對產業的影響(價值鏈·短期/中期/長期的影響)

第6章 全球直腸陰道瘺治療市場分析與預測:各類型

  • 簡介和定義
  • 主要調查結果/開發趨勢
  • 市場金額預測:各類型,2017年∼2031年
    • 高位直腸陰道瘺
    • 低位直腸陰道瘺
    • 中位直腸陰道瘺
  • 市場魅力分析:各類型

第7章 全球直腸陰道瘺治療市場分析與預測:各終端用戶

  • 簡介和定義
  • 主要調查結果/開發趨勢
  • 市場金額預測:各終端用戶,2017∼2031年
    • 醫院
    • 門診病人手術中心
    • 其他
  • 市場魅力分析:各終端用戶

第8章 全球直腸陰道瘺治療市場分析與預測:不同治療

  • 簡介和定義
  • 主要調查結果/開發趨勢
  • 市場金額預測:不同治療,2017年∼2031年
    • 投藥療法
    • 手術
  • 市場魅力分析:不同治療

第9章 全球直腸陰道瘺治療市場分析與預測:各適應症

  • 簡介和定義
  • 主要調查結果/開發趨勢
  • 市場金額預測:各適應症,2017年∼2031年
    • 克隆氏症
    • 分娩相關傷害
    • 癌症腫瘤治療
    • 其他
  • 市場魅力分析:各適應症

第10章 全球直腸陰道瘺治療市場分析與預測:各地區

  • 主要調查結果
  • 市場金額預測:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力分析:各國/各地區

第11章 北美的直腸陰道瘺治療市場分析與預測

  • 簡介
    • 主要調查結果
  • 市場金額預測:各類型,2017年∼2031年
    • 高位的直腸陰道瘺
    • 低位的直腸陰道瘺
    • 中間位的直腸陰道瘺
  • 市場金額預測:各終端用戶,2017∼2031年
    • 醫院
    • 門診病人手術中心
    • 其他
  • 市場金額預測:不同治療,2017年∼2031年
    • 投藥療法
    • 手術
  • 市場金額預測:各適應症,2017年∼2031年
    • 克隆氏症
    • 分娩相關傷害
    • 癌症腫瘤治療
    • 其他
  • 市場金額預測:各國,2017年∼2031年
    • 美國
    • 加拿大
  • 市場魅力分析
    • 各類型
    • 各終端用戶
    • 不同治療
    • 各適應症
    • 各國

第12章 歐洲的直腸陰道瘺治療市場分析與預測

第13章 亞太地區的直腸陰道瘺治療市場分析與預測

第14章 南美的直腸陰道瘺治療市場分析與預測

第15章 中東·非洲的直腸陰道瘺治療市場分析與預測

第16章 競爭情形

  • 市場企業 - 競爭矩陣(企業層級·各規模)
  • 企業簡介
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Sanofi S.A.
    • Takeda Pharmaceutical Company Limited
    • Johnson & Johnson Services, Inc.
    • W. L. Gore & Associates, Inc.
    • Mount Sinai Hospital
    • Tubingen University Hospital
    • St. Mark's Hospital
    • Apollo Hospitals Enterprise Ltd.
    • 其他
目錄
Product Code: TMRGL84309

Scope of the Report

TMR's report on the global recto-vaginal fistula treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global recto-vaginal fistula treatment market for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global recto-vaginal fistula treatment market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the recto-vaginal fistula treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global recto-vaginal fistula treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report recto-vaginal fistula treatment market light on the changing competitive dynamics in the global recto-vaginal fistula treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global recto-vaginal fistula treatment market.

The report delves into the competition landscape of the global recto-vaginal fistula treatment market. Key players operating in the global recto-vaginal fistula treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global recto-vaginal fistula treatment market profiled in this report.

Key Questions Answered:

  • What is the sales/revenue generated by recto-vaginal fistula across all regions during the forecast period?
  • What are the opportunities in the global recto-vaginal fistula treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Research Objectives and Research Approach

The comprehensive report on the global recto-vaginal fistula treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global recto-vaginal fistula market in terms of type, end-user, indication, treatment, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global recto-vaginal fistula treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Recto-vaginal Fistula Treatment Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Advancements & Innovations in Treatment Methods/Medications
  • 5.2. Disease Epidemiology Analysis
  • 5.3. Key Industry Events (mergers, acquisitions, agreements / partnerships, etc.)
  • 5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Type, 2017-2031
    • 6.3.1. High Recto-vaginal Fistula
    • 6.3.2. Low Recto-vaginal Fistula
    • 6.3.3. Midzone Fistula
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by End-user, 2017-2031
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by Treatment

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Treatment, 2017-2031
    • 8.3.1. Medication
      • 8.3.1.1. Antibiotics
      • 8.3.1.2. Biologics Therapy
    • 8.3.2. Surgery
      • 8.3.2.1. Sphincteroplasty Procedure
      • 8.3.2.2. Endorectal Advancement Flap Procedure
      • 8.3.2.3. Others
  • 8.4. Market Attractiveness Analysis, by Treatment

9. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by Indication

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by Indication, 2017-2031
    • 9.3.1. Crohn's Disease
    • 9.3.2. Delivery-related Injuries
    • 9.3.3. Cancerous Tumor Treatment
    • 9.3.4. Others
  • 9.4. Market Attractiveness Analysis, by Indication

10. Global Recto-vaginal Fistula Treatment Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Country/Region

11. North America Recto-vaginal Fistula Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type, 2017-2031
    • 11.2.1. High Recto-vaginal Fistula
    • 11.2.2. Low Recto-vaginal Fistula
    • 11.2.3. Midzone Fistula
  • 11.3. Market Value Forecast, by End-user, 2017-2031
    • 11.3.1. Hospitals
    • 11.3.2. Ambulatory Surgical Centers
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by Treatment, 2017-2031
    • 11.4.1. Medication
      • 11.4.1.1. Antibiotics
      • 11.4.1.2. Biologics Therapy
    • 11.4.2. Surgery
      • 11.4.2.1. Sphincteroplasty Procedure
      • 11.4.2.2. Endorectal Advancement Flap Procedure
      • 11.4.2.3. Others
  • 11.5. Market Value Forecast, by Indication, 2017-2031
    • 11.5.1. Crohn's Disease
    • 11.5.2. Delivery-related Injuries
    • 11.5.3. Cancerous Tumor Treatment
    • 11.5.4. Others
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Type
    • 11.7.2. By End-user
    • 11.7.3. By Treatment
    • 11.7.4. By Indication
    • 11.7.5. By Country

12. Europe Recto-vaginal Fistula Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2017-2031
    • 12.2.1. High Recto-vaginal Fistula
    • 12.2.2. Low Recto-vaginal Fistula
    • 12.2.3. Midzone Fistula
  • 12.3. Market Value Forecast, by End-user, 2017-2031
    • 12.3.1. Hospitals
    • 12.3.2. Ambulatory Surgical Centers
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Treatment, 2017-2031
    • 12.4.1. Medication
      • 12.4.1.1. Antibiotics
      • 12.4.1.2. Biologics Therapy
    • 12.4.2. Surgery
      • 12.4.2.1. Sphincteroplasty Procedure
      • 12.4.2.2. Endorectal Advancement Flap Procedure
      • 12.4.2.3. Others
  • 12.5. Market Value Forecast, by Indication, 2017-2031
    • 12.5.1. Crohn's Disease
    • 12.5.2. Delivery-related Injuries
    • 12.5.3. Cancerous Tumor Treatment
    • 12.5.4. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Type
    • 12.7.2. By End-user
    • 12.7.3. By Treatment
    • 12.7.4. By Indication
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Recto-vaginal Fistula Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2017-2031
    • 13.2.1. High Recto-vaginal Fistula
    • 13.2.2. Low Recto-vaginal Fistula
    • 13.2.3. Midzone Fistula
  • 13.3. Market Value Forecast, by End-user, 2017-2031
    • 13.3.1. Hospitals
    • 13.3.2. Ambulatory Surgical Centers
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Treatment, 2017-2031
    • 13.4.1. Medication
      • 13.4.1.1. Antibiotics
      • 13.4.1.2. Biologics Therapy
    • 13.4.2. Surgery
      • 13.4.2.1. Sphincteroplasty Procedure
      • 13.4.2.2. Endorectal Advancement Flap Procedure
      • 13.4.2.3. Others
  • 13.5. Market Value Forecast, by Indication, 2017-2031
    • 13.5.1. Crohn's Disease
    • 13.5.2. Delivery-related Injuries
    • 13.5.3. Cancerous Tumor Treatment
    • 13.5.4. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. Japan
    • 13.6.2. China
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of APAC
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Type
    • 13.7.2. By End-user
    • 13.7.3. By Treatment
    • 13.7.4. By Indication
    • 13.7.5. By Country/Sub-region

14. Latin America Recto-vaginal Fistula Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2017-2031
    • 14.2.1. High Recto-vaginal Fistula
    • 14.2.2. Low Recto-vaginal Fistula
    • 14.2.3. Midzone Fistula
  • 14.3. Market Value Forecast, by End-user, 2017-2031
    • 14.3.1. Hospitals
    • 14.3.2. Ambulatory Surgical Centers
    • 14.3.3. Others
  • 14.4. Market Value Forecast, by Treatment, 2017-2031
    • 14.4.1. Medication
      • 14.4.1.1. Antibiotics
      • 14.4.1.2. Biologics Therapy
    • 14.4.2. Surgery
      • 14.4.2.1. Sphincteroplasty Procedure
      • 14.4.2.2. Endorectal Advancement Flap Procedure
      • 14.4.2.3. Others
  • 14.5. Market Value Forecast, by Indication, 2017-2031
    • 14.5.1. Crohn's Disease
    • 14.5.2. Delivery-related Injuries
    • 14.5.3. Cancerous Tumor Treatment
    • 14.5.4. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of LATAM
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Type
    • 14.7.2. By End-user
    • 14.7.3. By Treatment
    • 14.7.4. By Indication
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Recto-vaginal Fistula Treatment Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Type, 2017-2031
    • 15.2.1. High Recto-vaginal Fistula
    • 15.2.2. Low Recto-vaginal Fistula
    • 15.2.3. Midzone Fistula
  • 15.3. Market Value Forecast, by End-user, 2017-2031
    • 15.3.1. Hospitals
    • 15.3.2. Ambulatory Surgical Centers
    • 15.3.3. Others
  • 15.4. Market Value Forecast, by Treatment, 2017-2031
    • 15.4.1. Medication
      • 15.4.1.1. Antibiotics
      • 15.4.1.2. Biologics Therapy
    • 15.4.2. Surgery
      • 15.4.2.1. Sphincteroplasty Procedure
      • 15.4.2.2. Endorectal Advancement Flap Procedure
      • 15.4.2.3. Others
  • 15.5. Market Value Forecast, by Indication, 2017-2031
    • 15.5.1. Crohn's Disease
    • 15.5.2. Delivery-related Injuries
    • 15.5.3. Cancerous Tumor Treatment
    • 15.5.4. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of MEA
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Type
    • 15.7.2. By End-user
    • 15.7.3. By Treatment
    • 15.7.4. By Indication
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by tier and size of companies)
  • 16.2. Company Profiles
    • 16.2.1. Pfizer Inc.
      • 16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.1.2. Company Financials
      • 16.2.1.3. Growth Strategies
      • 16.2.1.4. SWOT Analysis
    • 16.2.2. GlaxoSmithKline plc
      • 16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.2.2. Company Financials
      • 16.2.2.3. Growth Strategies
      • 16.2.2.4. SWOT Analysis
    • 16.2.3. Sanofi S.A.
      • 16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.3.2. Company Financials
      • 16.2.3.3. Growth Strategies
      • 16.2.3.4. SWOT Analysis
    • 16.2.4. Takeda Pharmaceutical Company Limited
      • 16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.4.2. Company Financials
      • 16.2.4.3. Growth Strategies
      • 16.2.4.4. SWOT Analysis
    • 16.2.5. Johnson & Johnson Services, Inc.
      • 16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.5.2. Company Financials
      • 16.2.5.3. Growth Strategies
      • 16.2.5.4. SWOT Analysis
    • 16.2.6. W. L. Gore & Associates, Inc.
      • 16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.6.2. Company Financials
      • 16.2.6.3. Growth Strategies
      • 16.2.6.4. SWOT Analysis
    • 16.2.7. Mount Sinai Hospital
      • 16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.7.2. Company Financials
      • 16.2.7.3. Growth Strategies
      • 16.2.7.4. SWOT Analysis
    • 16.2.8. Tubingen University Hospital
      • 16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.8.2. Company Financials
      • 16.2.8.3. Growth Strategies
      • 16.2.8.4. SWOT Analysis
    • 16.2.9. St. Mark's Hospital
      • 16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.9.2. Company Financials
      • 16.2.9.3. Growth Strategies
      • 16.2.9.4. SWOT Analysis
    • 16.2.10. Apollo Hospitals Enterprise Ltd.
      • 16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.10.2. Company Financials
      • 16.2.10.3. Growth Strategies
      • 16.2.10.4. SWOT Analysis
    • 16.2.11. Other Prominent Players
      • 16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.11.2. Company Financials
      • 16.2.11.3. Growth Strategies
      • 16.2.11.4. SWOT Analysis

List of Tables

  • Table 01: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 02: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 03: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 04: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017-2031
  • Table 05: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017-2031
  • Table 06: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 07: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 08: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 09: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 10: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 12: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017-2031
  • Table 13: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017-2031
  • Table 14: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 15: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 17: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 18: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 19: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017-2031
  • Table 20: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017-2031
  • Table 21: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 22: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 23: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 24: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 26: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017-2031
  • Table 27: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017-2031
  • Table 28: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 29: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 30: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 31: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 32: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 33: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017-2031
  • Table 34: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017-2031
  • Table 35: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 36: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 37: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 38: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 39: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 40: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Medication, 2017-2031
  • Table 41: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Surgery, 2017-2031
  • Table 42: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, by Indication, 2017-2031

List of Figures

  • Figure 01: Global Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Recto-vaginal Fistula Treatment Market Value Share, by Type, 2020
  • Figure 03: Global Recto-vaginal Fistula Treatment Market Value Share, by Indication, 2020
  • Figure 04: Global Recto-vaginal Fistula Treatment Market Value Share, by End-user, 2020
  • Figure 05: Global Recto-vaginal Fistula Treatment Market Value Share, by Treatment, 2020
  • Figure 06: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 07: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 08: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by High Recto-vaginal Fistula, 2017-2031
  • Figure 09: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Low Recto-vaginal Fistula, 2017-2031
  • Figure 10: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Midzone Fistula, 2017-2031
  • Figure 11: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 12: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 13: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 14: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2017-2031
  • Figure 15: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 16: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031
  • Figure 17: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021-2031
  • Figure 18: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Medication, 2017-2031
  • Figure 19: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Surgery, 2017-2031
  • Figure 20: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031
  • Figure 21: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021-2031
  • Figure 22: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Crohn's Disease, 2017-2031
  • Figure 23: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Delivery-related Injuries, 2017-2031
  • Figure 24: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Cancerous Tumor Treatment, 2017-2031
  • Figure 25: Global Recto-vaginal Fistula Treatment Market Revenue (US$ Mn), by Delivery-related Injuries, 2017-2031
  • Figure 26: Global Recto-vaginal Fistula Treatment Market Value Share Analysis, by Region, 2020 and 2031
  • Figure 27: Global Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 28: North America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 29: North America Recto-vaginal Fistula Treatment Market Value Share, by Country, 2020-2031
  • Figure 30: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country, 2021-2031
  • Figure 31: North America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 32: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 33: North America Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 34: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 35: North America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031
  • Figure 36: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021-2031
  • Figure 37: North America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031
  • Figure 38: North America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021-2031
  • Figure 39: Europe Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 40: Europe Recto-vaginal Fistula Treatment Market Value Share, by Country/Sub-region, 2020-2031
  • Figure 41: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 42: Europe Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 43: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 44: Europe Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 45: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 46: Europe Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031
  • Figure 47: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021-2031
  • Figure 48: Europe Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031
  • Figure 49: Europe Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021-2031
  • Figure 50: Asia Pacific Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 51: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share, by Country/Sub-region, 2020-2031
  • Figure 52: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 53: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 54: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 55: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 56: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 57: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031
  • Figure 58: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021-2031
  • Figure 59: Asia Pacific Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031
  • Figure 60: Asia Pacific Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021-2031
  • Figure 61: Latin America Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 62: Latin America Recto-vaginal Fistula Treatment Market Value Share, by Country/Sub-region, 2020-2031
  • Figure 63: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 64: Latin America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 65: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 66: Latin America Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 67: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 68: Latin America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031
  • Figure 69: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021-2031
  • Figure 70: Latin America Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031
  • Figure 71: Latin America Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021-2031
  • Figure 72: Middle East & Africa Recto-vaginal Fistula Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 73: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share, by Country/Sub-region, 2020-2031
  • Figure 74: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 75: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 76: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 77: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 78: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 79: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share Analysis, by Treatment, 2020 and 2031
  • Figure 80: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Treatment, 2021-2031
  • Figure 81: Middle East & Africa Recto-vaginal Fistula Treatment Market Value Share Analysis, by Indication, 2020 and 2031
  • Figure 82: Middle East & Africa Recto-vaginal Fistula Treatment Market Attractiveness Analysis, by Indication 2021-2031
  • Figure 83: Global Recto-vaginal Fistula Treatment Market Share, by Company, 2020